News
MissionIR News - Seeking Alpha Publishes Article Featuring CytRx Corp.
MissionIR would like to highlight CytRx Corp. (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology. The company’s pipeline is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. The Company also has rights to two additional drug candidates, tamibarotene and bafetinib.
In the company’s news,
Seeking Alpha yesterday published the following article featuring CytRx: http://seekingalpha.com/article/1700372-cytrx-corporation-remains-an-undiscovered-opportunity-inthe-cancer-space?source=yahoo#comments_headerThe article titled “CytRx Corporation Remains an Undiscovered Opportunity in the Cancer Space” provides an overview of the rapid growth taking place in emerging economies around the world. Featured alongside large-cap plays Celldex Therapeutics (NASDAQ: CLDX) and Seattle Genetics (NASDAQ: SGEN), CytRx was noted as being a compelling opportunity with significant potential in the oncology market.
The author of the article, penned under the name Equity Options Guru, writes: “Although CytRx is still a small company in terms of market capitalization, the fact remains that it is quickly becoming a diversified powerhouse with the potential to treat several illnesses within the oncology space. Given all the potential, it's surprising that the rest of the market hasn't caught on yet.”
For more information on CytRx Corp., visit http://www.MissionIR.com/CYTR.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
To sign up for The MissionIR Report, please visit http://MissionIR.com
To connect with MissionIR via Facebook, please visit http://Facebook.com/MissionIR
To connect with MissionIR via Twitter, please visit http://Twitter.com/MissionIR
Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
###
More News
MissionIR News - International Stem Cell Corporation (ISCO) has a Place in the SAGE Encyclopedia of Stem Cell Research
Released On: 4/8/2016
Views: 3861
MissionIR News - eXp Realty International Corporation (EXPI) Attains Exclusive Rights to VirBELA Platform within Real Estate Industry
Released On: 4/7/2016
Views: 4601
MissionIR News - Moxian (MOXC): Social Media is a Necessity for Small Businesses Too
Released On: 3/31/2016
Views: 3592
MissionIR News - OurPet’s Company (OPCO) Reaches Favorable Settlement in Patent Infringement Case
Released On: 3/24/2016
Views: 2926
MissionIR News - Content Checked Holdings (CNCK) Reminds Us That You Are What You Eat
Released On: 3/17/2016
Views: 2486
MissionIR News - Oakridge Global Energy Solutions, Inc. (OGES) Promises Your Machine Will Start Every Time with its Lithium-Ion Battery
Released On: 3/11/2016
Views: 2330
MissionIR News - International Stem Cell Corp. (ISCO): Benefits of Stem Cells Outlined in Israel/California Collaboration
Released On: 3/4/2016
Views: 2626
MissionIR News - OurPet’s Company (OPCO) Adapting to a Constantly Changing Pet Products Industry with Innovation
Released On: 3/3/2016
Views: 2325
MissionIR News - Avoid Getting Poisoned with the Help of a Personal Food Taster from Content Checked Holdings (CNCK)
Released On: 2/23/2016
Views: 3676
MissionIR News - Oakridge Global Energy Solutions, Inc. (OGES) Ushering in a New Era in Battery Manufacturing
Released On: 2/12/2016
Views: 2682
MissionIR News - International Stem Cell Corp. (ISCO) Eyes Growth through Partnerships to Develop Therapeutic and Biomedical Products Worldwide
Released On: 2/10/2016
Views: 2394
MissionIR News - Torchlight Energy Resources, Inc. (TRCH) Moving Forward with Planning of Next Phase of Drilling on Orogrande Project
Released On: 2/9/2016
Views: 2549
MissionIR News - Content Checked Holdings, Inc. (CNCK) Updates Investors through Release of CEO’s Letter to Shareholders
Released On: 1/20/2016
Views: 4332
MissionIR News - International Stem Cell Corporation (ISCO) – Florey Clinical Service Agreement Expected to Deliver Results Later this Year
Released On: 1/14/2016
Views: 4801
MissionIR News - Moxian (MOXC) Announces Launch of New Subsidiary in Beijing
Released On: 1/5/2016
Views: 3027
MissionIR News - Elephant Talk Communications (ETAK) Initiates Restructuring of Global Business Operations with Executive and Board Appointments
Released On: 12/18/2015
Views: 9361
MissionIR News - International Stem Cell Corp. (ISCO) Has a Broad Pipeline of Targets
Released On: 12/9/2015
Views: 2792
MissionIR News - Oakridge Global Energy Solutions (OGES) is Flying High in the Drone Market
Released On: 12/3/2015
Views: 3239
